111.55
Healthequity Inc stock is traded at $111.55, with a volume of 1.89M.
It is down -1.02% in the last 24 hours and up +23.75% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$112.70
Open:
$111.13
24h Volume:
1.89M
Relative Volume:
1.55
Market Cap:
$8.70B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
102.34
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
+10.87%
1M Performance:
+23.75%
6M Performance:
+11.32%
1Y Performance:
+33.29%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
HQY
Healthequity Inc
|
111.55 | 8.70B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
VEEV
Veeva Systems Inc
|
285.36 | 45.71B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
58.85 | 9.78B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
41.16 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-22-25 | Resumed | RBC Capital Mkts | Outperform |
Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
Dec-04-24 | Initiated | Mizuho | Outperform |
Nov-15-24 | Initiated | Goldman | Neutral |
Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
Apr-02-24 | Reiterated | JP Morgan | Overweight |
Jan-03-24 | Initiated | Barclays | Overweight |
Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Jul-12-22 | Initiated | Goldman | Sell |
Apr-11-22 | Initiated | Wells Fargo | Overweight |
Apr-07-22 | Initiated | Guggenheim | Buy |
Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-02-21 | Initiated | Jefferies | Buy |
Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Jul-02-21 | Initiated | Stephens | Overweight |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Jan-07-21 | Initiated | BTIG Research | Neutral |
Dec-08-20 | Reiterated | Barrington Research | Outperform |
Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
Apr-14-20 | Initiated | Guggenheim | Buy |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Mar-17-20 | Reiterated | Barrington Research | Outperform |
Oct-07-19 | Initiated | Goldman | Neutral |
Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
May-23-18 | Initiated | BofA/Merrill | Buy |
Apr-24-18 | Resumed | JP Morgan | Overweight |
Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Portside Wealth Group LLC Acquires Shares of 2,349 HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity (NASDAQ:HQY) Issues FY 2026 Earnings Guidance - MarketBeat
HealthEquity (NASDAQ:HQY) Upgraded to "Buy" at Wall Street Zen - MarketBeat
HealthEquity (NASDAQ:HQY) Issues Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Barrington Adjusts Price Target on HealthEquity to $125 From $112, Maintains Outperform Rating - marketscreener.com
HealthEquity, Inc. (NASDAQ:HQY) Stock Position Raised by Chesley Taft & Associates LLC - MarketBeat
Rhumbline Advisers Increases Position in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
Citizens JMP Hikes HealthEquity, Inc. (HQY) Target to $117 - MSN
HealthEquity (HQY) Receives Boost with Increased Price Target | - GuruFocus
HealthEquity (HQY) Price Target Raised by Barrington Research | - GuruFocus
HealthEquity (NASDAQ:HQY) Given New $125.00 Price Target at Barrington Research - MarketBeat
HealthEquity (HQY) Receives Boost with Increased Price Target | HQY Stock News - GuruFocus
HealthEquity price target raised to $125 from $112 at Barrington - TipRanks
Deutsche Bank Raises HealthEquity (HQY) Price Target to $115 | HQY Stock News - GuruFocus
Deutsche Bank Aktiengesellschaft Increases HealthEquity (NASDAQ:HQY) Price Target to $115.00 - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Q1 2026 Earnings Call Transcript - Insider Monkey
Deutsche Bank Boosts HealthEquity (HQY) Price Target to $115 | H - GuruFocus
HealthEquity price target raised to $115 from $98 at Deutsche Bank - TipRanks
Deutsche Bank Boosts HealthEquity (HQY) Price Target to $115 | HQY Stock News - GuruFocus
Deutsche Bank Adjusts HealthEquity Price Target to $115 From $98, Maintains Buy Rating - marketscreener.com
HealthEquity surges 9% on quarterly beats, boosted guidance - MSN
Zacks Investment Ideas feature highlights: Ollie's Bargain Outlet and HealthEquity - Yahoo Finance
Healthequity stock soars to all-time high of $115.64 By Investing.com - Investing.com South Africa
2,493 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by GTS Securities LLC - MarketBeat
HealthEquity Inc. Earnings Call Highlights Growth and Legislative Wins - TipRanks
HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by GAMMA Investing LLC - MarketBeat
2 Buy-Rated Stocks to Watch After Strong Q1 Results: OLLI, HQY - Yahoo Finance
HealthEquity Analysts Boost Their Forecasts After Upbeat Earnings - Benzinga
What are HSAs? HealthEquity's CEO explains the pros & cons - Yahoo Finance
HealthEquity (HQY) Price Target Raised by Goldman Sachs | HQY Stock News - GuruFocus
HealthEquity (NASDAQ:HQY) Price Target Raised to $104.00 - MarketBeat
HealthEquity, Inc. ($HQY) Stock: Surges 9%+ to Hit $113 All-Time High After Strong Q125 Earnings Beat - CoinCentral
HealthEquity Inc (HQY) Shares Up 9.2% on Jun 4 - GuruFocus
KeyBanc Increases HealthEquity (HQY) Price Target to $125 | HQY Stock News - GuruFocus
HealthEquity (HQY) Surges 9% on Strong Q1 Results and Raised FY2 - GuruFocus
HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y - Yahoo Finance
Healthequity stock soars to all-time high of $115.64 - Investing.com India
HealthEquity (NASDAQ:HQY) Sets New 1-Year High After Strong Earnings - MarketBeat
Royal Bank of Canada Forecasts Strong Price Appreciation for HealthEquity (NASDAQ:HQY) Stock - MarketBeat
HealthEquity (HQY) Price Target Raised by B of A Securities | HQ - GuruFocus
HealthEquity (HQY) Receives Target Price Boost from RBC Capital | HQY Stock News - GuruFocus
JMP Securities Raises HealthEquity (HQY) Price Target to $117 | - GuruFocus
HealthEquity (HQY) Price Target Raised by B of A Securities | HQY Stock News - GuruFocus
HealthEquity (NASDAQ:HQY) Stock Price Expected to Rise, JMP Securities Analyst Says - MarketBeat
JMP Securities Raises HealthEquity (HQY) Price Target to $117 | HQY Stock News - GuruFocus
Expert Outlook: HealthEquity Through The Eyes Of 10 Analysts - Benzinga
BTIG maintains buy rating for HealthEquity stock after strong earnings By Investing.com - Investing.com Nigeria
KeyBanc maintains overweight rating on HealthEquity stock - Investing.com India
RBC Capital Raises Target for HealthEquity (HQY) as Strong Perfo - GuruFocus
HealthEquity (HQY) Price Target Raised by BofA After Strong Quarter | HQY Stock News - GuruFocus
RBC Capital Raises Target for HealthEquity (HQY) as Strong Performance Continues | HQY Stock News - GuruFocus
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):